Document is current
Any future updates will be listed below
-
Authors
Wang, Xiaofang
Wang, Hong
Du, Xin
Wang, Zhiyan
Li, Chenglong
Anderson, Craig S.
Zhang, Jinying
Hou, Xiaotong
Dong, Jianzeng https://orcid.org/0000-0001-7299-7805
-
Funding
Funding for this research was provided by:
Key Technologies Research and Development Program (2016YFC1301000)
Capital Characteristic Clinic Project (Z161100000516017)
- License Information
-
More Information
Article History
Received: 19 May 2022
Accepted: 2 August 2022
First Online: 19 August 2022
Declarations
:
: This trial complied with the Declaration of Helsinki regarding the investigation of humans. Its ethical clearance, protocol (version 3.0 on September 25, 2019), and associated documents were approved by the Ethics Committee of Beijing Anzhen hospital (Approval ID: 2018013). Any significant modifications to the protocol will need approval from the ethics committee before implementation.Informed consent and written consent forms of patients are mandatory before study participation. After the participant has been assessed as eligible, they or their guardians will be invited by the treating physicians to discuss the details and sign the informed consent. Additional consent provisions for use of participant data in ancillary studies are required. This trial does not involve collecting biological specimens for storage. Participants’ data is stored using a participant identification number, and the key to the identification code list is only available to the research team.
: Written informed consent was obtained from the participants to publish this manuscript and accompanying images.
: The authors declare that they have no competing interests.
